U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
IXEKIZUMAB
BTY153760O
US Approved Rx (2016)
First approved in 2016
General
Names
10
Classification
3
Identifiers
16
Subunits
4
Related Substances
1
IXEKIZUMAB
BTY153760O
US Approved Rx (2016)
First approved in 2016
General
Approval Year
2016
494
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
IXEKIZUMAB
Official Name
English
TALTZ
Preferred Name
English
LY-2439821
Code
English
IXEKIZUMAB [USAN]
Common Name
English
IXEKIZUMAB [JAN]
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
SKIN DEISEASES, PAPULOSQUAMOUS
EMA EPAR
SKIN AND CONNECTIVE TISSUE DISEASES
SKIN DISEASES
SKIN DEISEASES, PAPULOSQUAMOUS
PSORIASIS
EMA ASSESSMENT REPORTS
TALTZ (AUTHORIZED: PSORIASIS)
Interleukin inhibitors
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
Interleukin inhibitors
ixekizumab
WHO-ATC
L04AC13
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Interleukin-17A Antagonist
[EPC]
NDF-RT
N0000191495
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
16
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
DAILYMED
BTY153760O
PRIMARY
ChEMBL
CHEMBL1743034
PRIMARY
CAS
1143503-69-8
PRIMARY
MERCK INDEX
m11937
PRIMARY
WIKIPEDIA
IXEKIZUMAB
PRIMARY
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
BTY153760O
IXEKIZUMAB
